Advertisement

Topics

Jazz Pharmaceuticals Plc JAZZ Financial and Strategic SWOT Analysis Review Prices from USD $125

12:48 EST 11 Jan 2017 | BioPortfolio Reports

Jazz Pharmaceuticals Plc JAZZ Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.

Highlights

Jazz Pharmaceuticals Plc Jazz is a specialty biopharmaceutical company which identifies, develops and commercializes novel therapeutic products with a focus on narcolepsy, cancer, pain and psychiatry. Its major marketed products under brand Xyrem for the treatment of cataplexy and excessive daytime sleepiness in patients with narcolepsy; Erwinaze for acute lymphoblastic leukemia; Prialt for severe chronic pain in patients who are intolerant or refractory to other treatments and FazaClo for orally disintegrating clozapine tablets indicated for treatmentresistant schizophrenia. The company sells its products through a network of local distributors and wholesalers. It has operations in the US, Bermuda and France. Jazz is headquartered Dublin, Ireland.

Jazz Pharmaceuticals Plc Key Recent Developments

Oct 25, 2016: Life Science Providers Deploy Comprehend Systems' Clinical Intelligence Suite to Improve the Speed and Quality of Clinical Trials
Aug 09, 2016: Jazz Pharmaceuticals Announces Second Quarter 2016 Financial Results
Jul 15, 2016: PhRMA Welcomes Five New Member Companies
May 10, 2016: Jazz Pharmaceuticals Announces First Quarter 2016 Financial Results
Feb 23, 2016: Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2015 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Jazz Pharmaceuticals Plc JAZZ Financial and Strategic SWOT Analysis Review Prices from USD $125

NEXT ARTICLE

More From BioPortfolio on "Jazz Pharmaceuticals Plc JAZZ Financial and Strategic SWOT Analysis Review Prices from USD $125"

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Sleep Disorders
Sleep disorders disrupt sleep during the night, or cause sleepiness during the day, caused by physiological or psychological factors. The common ones include snoring and sleep apnea, insomnia, parasomnias, sleep paralysis, restless legs syndrome, circa...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...